Poseida Therapeutics, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Poseida Therapeutics, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$35.41 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2024-11-07
- Poseida Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was $20.23M.
- Poseida Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$31.37M.
- Poseida Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$24.27M.
- Poseida Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was -$25.35M.
- Poseida Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$123.43M.
- Poseida Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$64.00M.
- Poseida Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$124.97M.
- Poseida Therapeutics, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$129.78M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2024-09-30 | $20.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$11.14M derived: sum of 2 quarters · filed 2024-11-07 | -$35.41M 10-Q · filed 2024-11-07 | -$60.76M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | -$31.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$55.65M 10-Q · filed 2024-08-05 | -$80.99M derived: sum of 3 quarters · filed 2024-08-05 | -$112.77M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | -$24.27M 10-Q · filed 2024-05-14 | -$49.62M derived: sum of 2 quarters · filed 2024-05-14 | -$81.40M derived: sum of 3 quarters · filed 2024-11-07 | -$108.86M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | -$25.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$57.13M derived: sum of 2 quarters · filed 2024-11-07 | -$84.58M derived: sum of 3 quarters · filed 2024-11-07 | -$123.43M 10-K · filed 2024-03-07 |
| 2023-09-30 | -$31.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$59.23M derived: sum of 2 quarters · filed 2024-11-07 | -$98.08M 10-Q · filed 2024-11-07 | -$131.40M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$27.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$66.30M 10-Q · filed 2024-08-05 | -$99.62M derived: sum of 3 quarters · filed 2024-08-05 | -$29.21M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | -$38.85M 10-Q · filed 2024-05-14 | -$72.17M derived: sum of 2 quarters · filed 2024-05-14 | -$1.76M derived: sum of 3 quarters · filed 2024-05-14 | -$44.79M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$33.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $37.09M derived: sum of 2 quarters · filed 2024-03-07 | -$5.95M derived: sum of 3 quarters · filed 2024-03-07 | -$64.00M 10-K · filed 2024-03-07 |
| 2022-09-30 | $70.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $27.37M derived: sum of 2 quarters · filed 2023-11-09 | -$30.68M 10-Q · filed 2023-11-09 | -$29.21M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$43.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$101.09M 10-Q · filed 2023-08-08 | -$99.62M derived: sum of 3 quarters · filed 2023-08-08 | -$142.05M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$58.06M 10-Q · filed 2023-05-09 | -$56.59M derived: sum of 2 quarters · filed 2023-05-09 | -$99.01M derived: sum of 3 quarters · filed 2023-05-09 | -$144.72M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$40.95M derived: sum of 2 quarters · filed 2023-03-09 | -$86.66M derived: sum of 3 quarters · filed 2023-03-09 | -$124.97M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$42.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$88.13M derived: sum of 2 quarters · filed 2022-11-10 | -$126.44M 10-Q · filed 2022-11-10 | -$162.59M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$45.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$84.02M 10-Q · filed 2022-08-11 | -$120.17M derived: sum of 3 quarters · filed 2022-08-11 | -$154.58M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$38.31M 10-Q · filed 2022-05-12 | -$74.46M derived: sum of 2 quarters · filed 2022-05-12 | -$108.88M derived: sum of 3 quarters · filed 2022-05-12 | -$139.31M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$36.15M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$70.56M derived: sum of 2 quarters · filed 2022-03-10 | -$100.99M derived: sum of 3 quarters · filed 2022-03-10 | -$129.78M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$34.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$64.84M derived: sum of 2 quarters · filed 2021-11-09 | -$93.63M 10-Q · filed 2021-11-09 | -$117.24M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$30.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$59.21M 10-Q · filed 2021-08-12 | -$82.83M derived: sum of 3 quarters · filed 2021-08-12 | -$103.78M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$28.78M 10-Q · filed 2021-05-11 | -$52.40M derived: sum of 2 quarters · filed 2021-05-11 | -$73.35M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | -$23.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$44.57M derived: sum of 2 quarters · filed 2021-03-11 | -$86.53M 10-K · filed 2021-03-11 | |
| 2019-09-30 | -$20.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$62.91M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$41.96M 10-Q · filed 2020-08-20 |